| 000 | 01806 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516223141.0 | ||
| 264 | 0 | _c20141125 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.114.212779 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZwart, R | |
| 245 | 0 | 0 |
_aPerampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cOct 2014 |
||
| 300 |
_a124-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAction Potentials |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aPyridones _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, AMPA _xantagonists & inhibitors |
| 650 | 0 | 4 | _aXenopus |
| 700 | 1 | _aSher, E | |
| 700 | 1 | _aPing, X | |
| 700 | 1 | _aJin, X | |
| 700 | 1 | _aSims, J R | |
| 700 | 1 | _aChappell, A S | |
| 700 | 1 | _aGleason, S D | |
| 700 | 1 | _aHahn, P J | |
| 700 | 1 | _aGardinier, K | |
| 700 | 1 | _aGernert, D L | |
| 700 | 1 | _aHobbs, J | |
| 700 | 1 | _aSmith, J L | |
| 700 | 1 | _aValli, S N | |
| 700 | 1 | _aWitkin, J M | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 351 _gno. 1 _gp. 124-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.114.212779 _zAvailable from publisher's website |
| 999 |
_c24009883 _d24009883 |
||